Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Subcutaneous Immunoglobulins Market Research Report 2025

Global Subcutaneous Immunoglobulins Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 73 Pages

Report ld: 3472128

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Subcutaneous Immunoglobulins Market Size(US$)

CAGR 2025-2031

12.1%

Market Size,2031

USD 12,050

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 6,087 million

Market Forecast in 2031(Value)

US$ 12,050 million

CAGR

12.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Subcutaneous Immunoglobulins was valued at US$ 5491 million in the year 2024 and is projected to reach a revised size of US$ 12050 million by 2031, growing at a CAGR of 12.1% during the forecast period.

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.

South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.

In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Immunoglobulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Immunoglobulins.

The Subcutaneous Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Immunoglobulins market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Subcutaneous Immunoglobulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.

By Company

Shire (Baxalta)

Grifols

CSL

Segment by Purity

0.1

0.2

Segment by Application

Primary Immunodeficiency

Secondary Immunodeficiency

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Subcutaneous Immunoglobulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Subcutaneous Immunoglobulins Market Overview

1.1 Product Definition

1.2 Subcutaneous Immunoglobulins by Purity

1.2.1 Global Subcutaneous Immunoglobulins Market Value Comparison by Purity (2024 VS 2031)

1.2.2 0.1

1.2.3 0.2

1.3 Subcutaneous Immunoglobulins by Application

1.3.1 Global Subcutaneous Immunoglobulins Market Value by Application (2024 VS 2031)

1.3.2 Primary Immunodeficiency

1.3.3 Secondary Immunodeficiency

1.3.4 Others

1.4 Global Subcutaneous Immunoglobulins Market Size Estimates and Forecasts

1.4.1 Global Subcutaneous Immunoglobulins Revenue 2020-2031

1.4.2 Global Subcutaneous Immunoglobulins Sales 2020-2031

1.4.3 Global Subcutaneous Immunoglobulins Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Subcutaneous Immunoglobulins Market Competition by Manufacturers

2.1 Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturers (2020-2025)

2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Subcutaneous Immunoglobulins Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Subcutaneous Immunoglobulins, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Subcutaneous Immunoglobulins, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Subcutaneous Immunoglobulins, Product Type & Application

2.7 Global Key Manufacturers of Subcutaneous Immunoglobulins, Date of Enter into This Industry

2.8 Global Subcutaneous Immunoglobulins Market Competitive Situation and Trends

2.8.1 Global Subcutaneous Immunoglobulins Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Subcutaneous Immunoglobulins Players Market Share by Revenue

2.8.3 Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Subcutaneous Immunoglobulins Market Scenario by Region

3.1 Global Subcutaneous Immunoglobulins Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Subcutaneous Immunoglobulins Sales by Region: 2020-2031

3.2.1 Global Subcutaneous Immunoglobulins Sales by Region: 2020-2025

3.2.2 Global Subcutaneous Immunoglobulins Sales by Region: 2026-2031

3.3 Global Subcutaneous Immunoglobulins Revenue by Region: 2020-2031

3.3.1 Global Subcutaneous Immunoglobulins Revenue by Region: 2020-2025

3.3.2 Global Subcutaneous Immunoglobulins Revenue by Region: 2026-2031

3.4 North America Subcutaneous Immunoglobulins Market Facts & Figures by Country

3.4.1 North America Subcutaneous Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Subcutaneous Immunoglobulins Sales by Country (2020-2031)

3.4.3 North America Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Subcutaneous Immunoglobulins Market Facts & Figures by Country

3.5.1 Europe Subcutaneous Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Subcutaneous Immunoglobulins Sales by Country (2020-2031)

3.5.3 Europe Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Subcutaneous Immunoglobulins Market Facts & Figures by Region

3.6.1 Asia Pacific Subcutaneous Immunoglobulins Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2020-2031)

3.6.3 Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Subcutaneous Immunoglobulins Market Facts & Figures by Country

3.7.1 Latin America Subcutaneous Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Subcutaneous Immunoglobulins Sales by Country (2020-2031)

3.7.3 Latin America Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Subcutaneous Immunoglobulins Market Facts & Figures by Country

3.8.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2020-2031)

3.8.3 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Purity

4.1 Global Subcutaneous Immunoglobulins Sales by Purity (2020-2031)

4.1.1 Global Subcutaneous Immunoglobulins Sales by Purity (2020-2025)

4.1.2 Global Subcutaneous Immunoglobulins Sales by Purity (2026-2031)

4.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2031)

4.2 Global Subcutaneous Immunoglobulins Revenue by Purity (2020-2031)

4.2.1 Global Subcutaneous Immunoglobulins Revenue by Purity (2020-2025)

4.2.2 Global Subcutaneous Immunoglobulins Revenue by Purity (2026-2031)

4.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2020-2031)

4.3 Global Subcutaneous Immunoglobulins Price by Purity (2020-2031)

5 Segment by Application

5.1 Global Subcutaneous Immunoglobulins Sales by Application (2020-2031)

5.1.1 Global Subcutaneous Immunoglobulins Sales by Application (2020-2025)

5.1.2 Global Subcutaneous Immunoglobulins Sales by Application (2026-2031)

5.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2031)

5.2 Global Subcutaneous Immunoglobulins Revenue by Application (2020-2031)

5.2.1 Global Subcutaneous Immunoglobulins Revenue by Application (2020-2025)

5.2.2 Global Subcutaneous Immunoglobulins Revenue by Application (2026-2031)

5.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2020-2031)

5.3 Global Subcutaneous Immunoglobulins Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Shire (Baxalta)

6.1.1 Shire (Baxalta) Company Information

6.1.2 Shire (Baxalta) Description and Business Overview

6.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio

6.1.5 Shire (Baxalta) Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Company Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Grifols Subcutaneous Immunoglobulins Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 CSL

6.3.1 CSL Company Information

6.3.2 CSL Description and Business Overview

6.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)

6.3.4 CSL Subcutaneous Immunoglobulins Product Portfolio

6.3.5 CSL Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Subcutaneous Immunoglobulins Industry Chain Analysis

7.2 Subcutaneous Immunoglobulins Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Subcutaneous Immunoglobulins Production Mode & Process Analysis

7.4 Subcutaneous Immunoglobulins Sales and Marketing

7.4.1 Subcutaneous Immunoglobulins Sales Channels

7.4.2 Subcutaneous Immunoglobulins Distributors

7.5 Subcutaneous Immunoglobulins Customer Analysis

8 Subcutaneous Immunoglobulins Market Dynamics

8.1 Subcutaneous Immunoglobulins Industry Trends

8.2 Subcutaneous Immunoglobulins Market Drivers

8.3 Subcutaneous Immunoglobulins Market Challenges

8.4 Subcutaneous Immunoglobulins Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Subcutaneous Immunoglobulins Market Value Comparison by Purity (2024 VS 2031) & (US$ Million)

Table 2. Global Subcutaneous Immunoglobulins Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Subcutaneous Immunoglobulins Market Competitive Situation by Manufacturers in 2024

Table 4. Global Subcutaneous Immunoglobulins Sales (K Bottle) of Key Manufacturers (2020-2025)

Table 5. Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Subcutaneous Immunoglobulins Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Subcutaneous Immunoglobulins Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Subcutaneous Immunoglobulins Average Price (USD/Bottle) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Subcutaneous Immunoglobulins, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Subcutaneous Immunoglobulins, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Subcutaneous Immunoglobulins, Product Type & Application

Table 12. Global Key Manufacturers of Subcutaneous Immunoglobulins, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Subcutaneous Immunoglobulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Subcutaneous Immunoglobulins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Subcutaneous Immunoglobulins Sales by Region (2020-2025) & (K Bottle)

Table 18. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2020-2025)

Table 19. Global Subcutaneous Immunoglobulins Sales by Region (2026-2031) & (K Bottle)

Table 20. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2026-2031)

Table 21. Global Subcutaneous Immunoglobulins Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2020-2025)

Table 23. Global Subcutaneous Immunoglobulins Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2026-2031)

Table 25. North America Subcutaneous Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 27. North America Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 28. North America Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Subcutaneous Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 32. Europe Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 33. Europe Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Subcutaneous Immunoglobulins Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2020-2025) & (K Bottle)

Table 37. Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2026-2031) & (K Bottle)

Table 38. Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Subcutaneous Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 42. Latin America Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 43. Latin America Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 47. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 48. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Purity (2020-2025)

Table 51. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Purity (2026-2031)

Table 52. Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2025)

Table 53. Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2026-2031)

Table 54. Global Subcutaneous Immunoglobulins Revenue (US$ Million) by Purity (2020-2025)

Table 55. Global Subcutaneous Immunoglobulins Revenue (US$ Million) by Purity (2026-2031)

Table 56. Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2020-2025)

Table 57. Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2026-2031)

Table 58. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Purity (2020-2025)

Table 59. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Purity (2026-2031)

Table 60. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Application (2020-2025)

Table 61. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Application (2026-2031)

Table 62. Global Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2025)

Table 63. Global Subcutaneous Immunoglobulins Sales Market Share by Application (2026-2031)

Table 64. Global Subcutaneous Immunoglobulins Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Subcutaneous Immunoglobulins Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2020-2025)

Table 67. Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2026-2031)

Table 68. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Application (2020-2025)

Table 69. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Application (2026-2031)

Table 70. Shire (Baxalta) Company Information

Table 71. Shire (Baxalta) Description and Business Overview

Table 72. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 73. Shire (Baxalta) Subcutaneous Immunoglobulins Product

Table 74. Shire (Baxalta) Recent Developments/Updates

Table 75. Grifols Company Information

Table 76. Grifols Description and Business Overview

Table 77. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 78. Grifols Subcutaneous Immunoglobulins Product

Table 79. Grifols Recent Developments/Updates

Table 80. CSL Company Information

Table 81. CSL Description and Business Overview

Table 82. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 83. CSL Subcutaneous Immunoglobulins Product

Table 84. CSL Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Subcutaneous Immunoglobulins Distributors List

Table 88. Subcutaneous Immunoglobulins Customers List

Table 89. Subcutaneous Immunoglobulins Market Trends

Table 90. Subcutaneous Immunoglobulins Market Drivers

Table 91. Subcutaneous Immunoglobulins Market Challenges

Table 92. Subcutaneous Immunoglobulins Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Subcutaneous Immunoglobulins

Figure 2. Global Subcutaneous Immunoglobulins Market Value Comparison by Purity (2020-2031) & (US$ Million)

Figure 3. Global Subcutaneous Immunoglobulins Market Share by Purity: 2024 & 2031

Figure 4. 0.1 Product Picture

Figure 5. 0.2 Product Picture

Figure 6. Global Subcutaneous Immunoglobulins Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Subcutaneous Immunoglobulins Market Share by Application: 2024 & 2031

Figure 8. Primary Immunodeficiency

Figure 9. Secondary Immunodeficiency

Figure 10. Others

Figure 11. Global Subcutaneous Immunoglobulins Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Subcutaneous Immunoglobulins Market Size (2020-2031) & (US$ Million)

Figure 13. Global Subcutaneous Immunoglobulins Sales (2020-2031) & (K Bottle)

Figure 14. Global Subcutaneous Immunoglobulins Average Price (USD/Bottle) & (2020-2031)

Figure 15. Subcutaneous Immunoglobulins Report Years Considered

Figure 16. Subcutaneous Immunoglobulins Sales Share by Manufacturers in 2024

Figure 17. Global Subcutaneous Immunoglobulins Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Subcutaneous Immunoglobulins Players: Market Share by Revenue in Subcutaneous Immunoglobulins in 2024

Figure 19. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Subcutaneous Immunoglobulins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Subcutaneous Immunoglobulins Sales Market Share by Country (2020-2031)

Figure 22. North America Subcutaneous Immunoglobulins Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Subcutaneous Immunoglobulins Sales Market Share by Country (2020-2031)

Figure 26. Europe Subcutaneous Immunoglobulins Revenue Market Share by Country (2020-2031)

Figure 27. Germany Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Subcutaneous Immunoglobulins Revenue Market Share by Region (2020-2031)

Figure 34. China Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Subcutaneous Immunoglobulins Sales Market Share by Country (2020-2031)

Figure 44. Latin America Subcutaneous Immunoglobulins Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Subcutaneous Immunoglobulins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Subcutaneous Immunoglobulins by Purity (2020-2031)

Figure 54. Global Revenue Market Share of Subcutaneous Immunoglobulins by Purity (2020-2031)

Figure 55. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Purity (2020-2031)

Figure 56. Global Sales Market Share of Subcutaneous Immunoglobulins by Application (2020-2031)

Figure 57. Global Revenue Market Share of Subcutaneous Immunoglobulins by Application (2020-2031)

Figure 58. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Application (2020-2031)

Figure 59. Subcutaneous Immunoglobulins Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Subcutaneous Immunoglobulins in 2031? zhanKai

The global market size of Subcutaneous Immunoglobulins in 2031 was 12050 Million USD.

What is the annual compound growth rate of the global Subcutaneous Immunoglobulins market size from 2025 to 2031? shouQi

Which companies rank high in the global Subcutaneous Immunoglobulins market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Subcutaneous Immunoglobulins in 2025? shouQi

Related Reports

Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Subcutaneous Immunoglobulins market size was US$ 6087 million in 2025 and is forecast to reach a readjusted size of US$ 13360 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 65
USD 4250.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2026
The global Subcutaneous Immunoglobulins market was valued at US$ 6087 million in 2025 and is anticipated to reach US$ 13360 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 103
USD 2900.00
(Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 6087 million in 2025 and is projected to reach US$ 13360 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 80
USD 3950.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Subcutaneous Immunoglobulins market is projected to grow from US$ 5491 million in 2024 to US$ 12050 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 125
USD 4900.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million and is forecast to reach approximately US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 113
USD 5900.00
(Single User License)
Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Subcutaneous Immunoglobulins market size was US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 70
USD 4250.00
(Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 90
USD 3950.00
(Single User License)
Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-17
Pages: 121
USD 5600.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-16
Pages: 128
USD 5900.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-07
Pages: 70
USD 4900.00
(Single User License)

Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Subcutaneous Immunoglobulins market size was US$ 6087 million in 2025 and is forecast to reach a readjusted size of US$ 13360 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 65
USD 4250.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2026
The global Subcutaneous Immunoglobulins market was valued at US$ 6087 million in 2025 and is anticipated to reach US$ 13360 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 103
USD 2900.00 (Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 6087 million in 2025 and is projected to reach US$ 13360 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 80
USD 3950.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Subcutaneous Immunoglobulins market is projected to grow from US$ 5491 million in 2024 to US$ 12050 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 125
USD 4900.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million and is forecast to reach approximately US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 113
USD 5900.00 (Single User License)
Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Subcutaneous Immunoglobulins market size was US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 70
USD 4250.00 (Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 90
USD 3950.00 (Single User License)
Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-17
Pages: 121
USD 5600.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-16
Pages: 128
USD 5900.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-07
Pages: 70
USD 4900.00 (Single User License)